Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines

<table>Significant cytokine levels (pg/mL) evaluated in cellular supernatant untreated and after treatment with doxorubicin (0.85 <i>μ</i>M) and tacrolimus (0.052 <i>μ</i>M) and cotreatment (0.42 <i>μ</i>M dox plus 0.026 <i>μ</i>M tacr).</table>

The Scientific World Journal

fig4

Figure 4

Figure 4: Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines 